RxDoctor Payments Data

Andrew Dicks, MD

Internal Medicine · Greenville, SCNPI 1619405180

Payments from drug & device makers

$3,472in general payments, 2019–2025

Across 101 payments — averaging $34.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Inari Medical, Inc.$2K
  • Johnson & Johnson$432
  • Janssen Scientific Affairs, LLC$326
  • Medtronic$138
  • Penumbra, Inc.$134
  • Stryker$120
  • plus $179 from 4 others

What the payments were for

  • Food & beverage$3,472100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,472 in reported general payments places this provider in the 80th percentile of 1,498 internal medicine providers in South Carolina.

See all internal medicine providers in South Carolina

Medicare billing

Part B allowed, 2024
$121,743
Medicare patients
1,730
Services billed
2,790

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban816$557,500
XareltoRivaroxaban247$193,931
Repatha SureclickEvolocumab40$25,720
Enoxaparin Sodium32$10,868
Cilostazol51$690
Warfarin Sodium45$659
ClopidogrelClopidogrel Bisulfate62$644
Rosuvastatin Calcium69$484
Gabapentin35$424
Pregabalin25$337
Ezetimibe18$221
Amitriptyline Hcl14$175
Pentoxifylline16$174
Atorvastatin Calcium21$160
Amlodipine Besylate20$137

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$432$193,931247 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,498 internal medicine providers in South Carolina.

Other internal medicine in Greenville

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →